Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Neonc Technologies, Inc.
Amgen
Var2 Pharmaceuticals
Vanderbilt University Medical Center
LigaChem Biosciences, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Bayer
Shandong Cancer Hospital and Institute
NGM Biopharmaceuticals, Inc
Vanderbilt-Ingram Cancer Center
Prelude Therapeutics
Eastern Cooperative Oncology Group
Roswell Park Cancer Institute
Celgene
AbbVie
Celldex Therapeutics
Abramson Cancer Center at Penn Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Medical University of South Carolina
AbbVie
Alliance for Clinical Trials in Oncology
SWOG Cancer Research Network
Dana-Farber Cancer Institute
University of Miami
University of Miami
Alliance for Clinical Trials in Oncology
Vanderbilt University
Radiation Therapy Oncology Group
University of Wisconsin, Madison
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Trials Ireland
Vanderbilt University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
East and North Hertfordshire NHS Trust